{
  "question_id": "giqqq25001",
  "category": "gi",
  "category_name": "Gastroenterology",
  "educational_objective": "Treat <i>Helicobacter pylori</i> infection persisting after treatment.",
  "metadata": {
    "care_types": [],
    "patient_types": [],
    "high_value_care": false,
    "hospitalist": false,
    "question_updated": "01/01/2026"
  },
  "question_text": "A 65-year-old man is evaluated after a positive stool antigen test for Helicobacter pylori infection obtained to confirm eradication after therapy. H. pylori gastritis was diagnosed in the setting of a duodenal ulcer. Four weeks ago, he completed a 14-day course of eradication therapy with optimized bismuth quadruple therapy. He reports taking all medications as prescribed during treatment and reports no upper gastrointestinal symptoms or melena. He has no known drug allergies.",
  "question_stem": "Which of the following is the most appropriate 14-day treatment regimen?",
  "options": [
    {
      "letter": "A",
      "text": "Amoxicillin, metronidazole, and omeprazole",
      "peer_percentage": 0
    },
    {
      "letter": "B",
      "text": "Amoxicillin, levofloxacin, and omeprazole",
      "peer_percentage": 0
    },
    {
      "letter": "C",
      "text": "Bismuth, metronidazole, omeprazole, and tetracycline",
      "peer_percentage": 0
    },
    {
      "letter": "D",
      "text": "Amoxicillin, rifabutin, and omeprazole",
      "peer_percentage": 0
    }
  ],
  "user_performance": {
    "user_answer": null,
    "correct_answer": "D",
    "result": null,
    "time_taken": null
  },
  "critique": "Amoxicillin, rifabutin, and omeprazole (Option D) for 14 days is an appropriate regimen for salvage treatment of Helicobacter pylori infection after failure of initial treatment with bismuth-based quadruple therapy. Treatment regimens for H. pylori should consist of at least three agents, including two antimicrobial agents and one antisecretory agent; treatment duration is typically 14 days. The salvage therapy regimen for patients with persistent infection despite first-line treatment should consist of different antibiotics from those used in the initial, unsuccessful regimen (Table: Treatment for Helicobacter pylori Infection). This strategy reduces the likelihood of antibiotic resistance, the major reason for treatment failure. Disruption of therapy can cause treatment failure, and the likelihood of treatment success diminishes with each successive treatment attempt. To maximize treatment success, it is essential to counsel the patient carefully on the importance of treatment adherence and potential adverse effects of the therapy. In this patient for whom initial bismuth-based quadruple therapy was ineffective, rifabutin-based therapy is a reasonable option for second-line treatment.The combination of amoxicillin, metronidazole, and omeprazole (Option A) is not a recognized treatment regimen for H. pylori in any setting. Because the likelihood of treatment success diminishes with each successive treatment attempt, treatment regimens must be chosen carefully. Therefore, this combination is not an appropriate option for this patient.Levofloxacin triple therapy (Option B) or vonoprazan-clarithromycin triple therapy could be considered; however, these regimens require proven levofloxacin-sensitivity or clarithromycin-sensitivity, respectively, before use. Because these sensitivities have not been proven in this patient, this combination would not be the most appropriate treatment.Salvage treatment with the same regimen of bismuth, metronidazole, omeprazole, and tetracycline (Option C) after failure of eradication is not appropriate. Salvage treatment should consist of a new regimen different from that used for initial treatment. This strategy reduces the likelihood of antibiotic resistance, which is the major reason for treatment failure. Therefore, a different regimen should be chosen for this patient.",
  "critique_links": [],
  "key_points": [
    "For Helicobacter pylori infection that persists after eradication therapy, the salvage therapy regimen should consist of different antibiotics from those used in the initial, unsuccessful regimen.",
    "To maximize the success of H. pylori treatment, patients must be counseled carefully on the importance of treatment adherence and potential adverse effects of the therapy."
  ],
  "references": "Chey WD, Howden CW, Moss SF, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024;119:1730-1753. PMID: 39626064 doi:10.14309/ajg.0000000000002968",
  "related_content": {
    "syllabus": [
      "gisec24002_24010"
    ]
  },
  "media": {
    "tables": [
      "tables/gitab25001.html"
    ],
    "images": [],
    "svgs": [],
    "videos": []
  },
  "media_metadata": {
    "figures": [],
    "tables": [
      {
        "table_id": "gitab25001",
        "file": "tables/gitab25001.html",
        "title": "First-Line and Salvage Treatment for <i>Helicobacter pylori</i> Infection",
        "short_title": "Treatment for <i>Helicobacter pylori</i> Infection",
        "footnotes": [
          "PCAB = potassium-competitive acid blocker; PPI = proton pump inhibitor.",
          "<sup>a</sup>Treatment duration is 14 days. Refer to Chey et al. (citation below) for dosing of each regimen component.",
          "Data from Chey WD, Howden CW, Moss SF, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024;119:1730-1753. <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/39626064\" target=\"_blank\">PMID: 39626064</a> doi:10.14309/ajg.0000000000002968"
        ],
        "headers": [
          "Treatment Regimena",
          "Comments/Indications",
          "First-Line Treatment",
          "Salvage Treatment"
        ]
      }
    ],
    "videos": [],
    "svgs": []
  },
  "extracted_at": "2026-01-01T17:54:31.420169-06:00"
}